TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
(NASDAQ:TLX), NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) — Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Telix Pharmaceuticals Limited (“Telix” or “the Company”) (NASDAQ: TLX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants […]